Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090346 · ClinicalTrials.gov registry record · Phase 4
Fecal Microbiota Transplant
A Phase 4 study, sponsored by Methodist Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT04090346 is a Phase 4 study that has completed, run by Methodist Health System. The registered enrollment target is 24 participants.
The verdict
NCT04090346, a Phase 4 study, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study will provide data to show the effectiveness of Fecal Microbiota Transplant in patients with recurrent Clostridium difficile infection. Fecal Microbiota Transplant (FMT) is a procedure in which healthy colon contents of a carefully screened donor is inserted into the colon of a compromised patient. FMT is a procedure to replace beneficial bacteria that has been killed or suppressed, most commonly by use of antibiotics. Currently it is utilized as an experimental treatment for Clostridium difficile infection (CDI). This procedure is predicted to reduce the cost both financially and physically for the CDI patient and facility.
Interventions
- DRUG Fecal Microbiota Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-06-05 |
| Est. Completion | 2022-03-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090346
The ClinicalTrials.gov registry entry for NCT04090346 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplant is the first listed.
NCT04090346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04090346 about?
NCT04090346 is a clinical study titled "Fecal Microbiota Transplant". The study will provide data to show the effectiveness of Fecal Microbiota Transplant in patients with recurrent Clostridium difficile infection. Fecal Microbiota Transplant (FMT) is a procedure in which healthy colon contents of a carefully screened donor is inserted into the colon of a compromised...
What is the current status of trial NCT04090346?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2018-06-05. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT04090346?
The interventions under investigation include: Fecal Microbiota Transplant (DRUG).
Who is sponsoring clinical trial NCT04090346?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.